Replies to post #72184 on Biotech Values

[rkrw]

pcop's pipeline was not so good. That's pretty much how they got in that mess in the first place, spending too much money and unable to sign major jv's. From an interview I read, the ceo claimed the driver was all the chemistry partnerships.